Global Assay Systems and Affinity Technologies Usage in Academia, Biotech and CROs

CHALLENGE

Our client, an international consulting firm, aimed to delve into the landscape of affinity technologies used in drug discovery and development. The goal was to understand the use and impact of various assay systems, such as HIPStA, CETSA, NanoBRET, and BLI, across different sectors including academia, biotech, and pharma. The focus was twofold: understanding the experiences of users of these technologies and gaining insights from general market experts about trends, key players, and purchasing criteria.

OUR APPROACH

To address these objectives, BTHT team started sourcing for experts across two main categories:

• Potential Users: We spoke with professionals who have firsthand experience with various assay systems for target engagement. These individuals were involved in early-stage drug research within academia, biotech, and pharma, or at CROs. Our experts included:
  • Associate Director
  • Senior Scientist
  • Principal Scientist
  • Former Research Scientist
  • Former Director of Research
• General Market Experts: We contacted with industry experts knowledgeable about affinity technologies and methodologies. These experts had experience in R&D, management, or business development roles, and were familiar with trends and key players in the market. Our experts included:
  • Market Analysts
  • Business Development Managers
  • Technology Consultants
• Key Questions Explored:
  • For Potential Users:
    • Review on assay systems like HIPStA, CETSA, NanoBRET, or BLI.
    • Use cases do you typically addressed with these technologies.
    • Notable companies behind them.
  • For General Market Experts:
    • Leading players.
    • Current trends in this market.
    • Criteria for selecting these technologies.

BTHT actively scheduled and participated in the consultation in order to ensure smooth communication between the client and the experts, and to maintain confidentiality.

OUTCOME

BTHT's experts provided a detailed understanding of affinity technologies and their applications in drug discovery. By gathering insights from both users and market experts, the client got a clear picture of current trends, technological differences, and key purchasing factors, in order to navigate and strategize in this evolving field.